-
Something wrong with this record ?
The effects of siRNA-mediated RGS4 gene silencing on the whole genome transcription profile: implications for schizophrenia
M. Vrajová, S. Peková, J. Horácek, C. Höschl,
Language English Country Sweden
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
21712773
Knihovny.cz E-resources
- MeSH
- Cell Line MeSH
- Down-Regulation MeSH
- Transcription, Genetic MeSH
- Genome, Human genetics MeSH
- Histones genetics MeSH
- Cells, Cultured MeSH
- Humans MeSH
- RNA, Small Interfering pharmacology MeSH
- Microarray Analysis MeSH
- Brain-Derived Neurotrophic Factor genetics MeSH
- Neurons drug effects metabolism MeSH
- Nerve Tissue Proteins genetics MeSH
- RGS Proteins genetics MeSH
- Receptors, G-Protein-Coupled genetics MeSH
- Schizophrenia genetics MeSH
- Gene Expression Profiling MeSH
- Gene Silencing MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVE: The regulator of G-protein signaling (RGS) molecules represent a class of proteins that modulate the signaling activity of G-protein coupled receptors. Regulator of G-protein signaling 4 (RGS4) is of particular interest in schizophrenia due to reported downregulation of RGS4 transcripts in schizophrenia as well as a connection between RGS4 and a number of receptors implicated in schizophrenia. The mechanism of RGS4 involvement in the pathophysiology of this illness is not clear. METHODS: To elucidate thise role of RGS4 in pathophysiology of schizophrenia, we silenced RGS4 using siRNAs in human neuroblastoma cell lines and we studied the effects of differential RGS4 expression by microarray. RESULTS AND CONCLUSION: The cell lines with downregulated expression of RGS4 showed 67 genes with changed expression (30 underexpressed and 37 overexpressed). We have detected three subgroups of genes which might be implicated in schizophrenia pathophysiology: histone genes, which suggest epigenetic mechanisms of the disease; genes for transcription factors associated with other genes relevant to schizophrenia pathology (BDNF and DISCI1) and a heterogeneous group containing genes for G-proteins (GPR50 and GPR64) and calcium binding proteins.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027484
- 003
- CZ-PrNML
- 005
- 20121210104453.0
- 007
- ta
- 008
- 120817s2011 sw f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)21712773
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Vrajová, Monika $u Prague Psychiatric Centre, Czech Republic. vrajova@pcp.lf3.cuni.cz
- 245 14
- $a The effects of siRNA-mediated RGS4 gene silencing on the whole genome transcription profile: implications for schizophrenia / $c M. Vrajová, S. Peková, J. Horácek, C. Höschl,
- 520 9_
- $a OBJECTIVE: The regulator of G-protein signaling (RGS) molecules represent a class of proteins that modulate the signaling activity of G-protein coupled receptors. Regulator of G-protein signaling 4 (RGS4) is of particular interest in schizophrenia due to reported downregulation of RGS4 transcripts in schizophrenia as well as a connection between RGS4 and a number of receptors implicated in schizophrenia. The mechanism of RGS4 involvement in the pathophysiology of this illness is not clear. METHODS: To elucidate thise role of RGS4 in pathophysiology of schizophrenia, we silenced RGS4 using siRNAs in human neuroblastoma cell lines and we studied the effects of differential RGS4 expression by microarray. RESULTS AND CONCLUSION: The cell lines with downregulated expression of RGS4 showed 67 genes with changed expression (30 underexpressed and 37 overexpressed). We have detected three subgroups of genes which might be implicated in schizophrenia pathophysiology: histone genes, which suggest epigenetic mechanisms of the disease; genes for transcription factors associated with other genes relevant to schizophrenia pathology (BDNF and DISCI1) and a heterogeneous group containing genes for G-proteins (GPR50 and GPR64) and calcium binding proteins.
- 650 _2
- $a mozkový neurotrofický faktor $x genetika $7 D019208
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a down regulace $7 D015536
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a umlčování genů $7 D020868
- 650 _2
- $a genom lidský $x genetika $7 D015894
- 650 _2
- $a histony $x genetika $7 D006657
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikročipová analýza $7 D046228
- 650 _2
- $a proteiny nervové tkáně $x genetika $7 D009419
- 650 _2
- $a neurony $x účinky léků $x metabolismus $7 D009474
- 650 _2
- $a proteiny RGS $x genetika $7 D020710
- 650 _2
- $a malá interferující RNA $x farmakologie $7 D034741
- 650 _2
- $a receptory spřažené s G-proteiny $x genetika $7 D043562
- 650 _2
- $a schizofrenie $x genetika $7 D012559
- 650 _2
- $a genetická transkripce $7 D014158
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Peková, Soňa
- 700 1_
- $a Horácek, Jirí
- 700 1_
- $a Höschl, Cyril
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 32, č. 3 (2011), s. 246-52
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21712773 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121210104530 $b ABA008
- 999 __
- $a ok $b bmc $g 949526 $s 784830
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 32 $c 3 $d 246-52 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20120817/11/03